<SEC-DOCUMENT>0001193125-18-200656.txt : 20180622
<SEC-HEADER>0001193125-18-200656.hdr.sgml : 20180622
<ACCEPTANCE-DATETIME>20180622123104
ACCESSION NUMBER:		0001193125-18-200656
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180621
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180622
DATE AS OF CHANGE:		20180622

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		18913912

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		949-260-1200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d627278d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): June&nbsp;21, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-13795</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">95-2588080</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Commission File Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4695 MacArthur Court </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Newport Beach, California 92660 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number: (949) <FONT STYLE="white-space:nowrap">260-1200</FONT> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b02 of the Securities Exchange Act of 1934 (&#167;240.12b02 of this chapter). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B>Emerging Growth
Company&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;21, 2018, American Vanguard Corporation issued a press release announcing the
completion of the acquisition of certain assets related to the Bromacil herbicide business of Bayer CropScience. That release is attached hereto as Exhibit 99.1 and is incorporated by reference herein in its entirety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> including the Exhibit attached hereto, is being
furnished under Items 8.01 and 9.01 and shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d627278dex991.htm">Press release dated June&nbsp;21, 2018 of American Vanguard Corporation announcing the completion of the Bromacil acquisition.</A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">AMERICAN VANGUARD CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: June 22, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Timothy J. Donnelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Timothy J. Donnelly</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Administrative Officer, General Counsel</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&amp;&nbsp;Secretary</P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d627278dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g627278g52l58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMVAC Chemical Acquires Bromacil Herbicide Business Assets from Bayer Crop Science </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEWPORT BEACH, California &#150; June&nbsp;21, 2018 &#150; AMVAC Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation (NYSE:AVD),
today announced the purchase of the Bromacil herbicide business in the United States and Canada from Bayer Crop Science. This divestment is unrelated to the acquisition of Monsanto by Bayer, and financial terms of the agreement were not disclosed.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The assets being purchased include the Bromacil trademarks and product registrations for Hyvar<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
and Krovar<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> in the USA and Canada. In order to ensure the best customer service and a seamless transition, Bayer Crop Science will continue to market and provide customer support for these
products until the end of September 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bromacil is a broad spectrum residual herbicide used for
<FONT STYLE="white-space:nowrap">non-agricultural</FONT> industrial vegetation control and on many crops such as pineapples, citrus, agave and asparagus. Marketed under the Hyvar<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Krovar<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> brands, Bromacil herbicides are valued and long established weed control tools. AMVAC previously secured ownership of these brands from DuPont Crop Protection in 2015 for markets outside of US
and Canada including Japan, Thailand, Mexico, Cost Rica and Brazil. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eric Wintemute, Chairman&nbsp;&amp; CEO of American Vanguard commented: &#147;These
proven weed management products will strengthen our competitive position in serving many niche crop markets and also allow us to expand AMVAC&#146;s participation in the industrial vegetation management business. Along with other initiatives that we
are pursuing, acquiring these Bromacil herbicide assets will enhance the breadth of our domestic herbicide portfolio. We have a history of excellent working relationships with Bayer Crop Science and are delighted to be carrying this successful
product line forward.&#148; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About American Vanguard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and Russell
3000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Indexes and the Standard&nbsp;&amp; Poor&#146;s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company&#146;s web site at
<U>www.american-vanguard.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company, from time to time, may discuss forward-looking information. Except for the historical information
contained in this release, all forward-looking statements are estimates by the Company&#146;s management and are subject to various risks and uncertainties that may cause results to differ from management&#146;s current expectations. Such factors
include weather conditions, changes in regulatory policy and other risks as detailed from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> in the Company&#146;s SEC reports and filings. All forward-looking
statements, if any, in this release represent the Company&#146;s judgment as of the date of this release. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Company Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Investor Representative</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">American Vanguard Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Equity Group Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">William A. Kuser, Director of Investor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">www.theequitygroup.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(949) <FONT STYLE="white-space:nowrap">260-1200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lena Cati (212) <FONT STYLE="white-space:nowrap">836-9611</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">williamk@amvac-chemical.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lcati@equityny.com</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g627278g52l58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g627278g52l58.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0!:17AI9@  24DJ  @    %  $#!0 !
M    2@    ,# 0 !     #)5 !!1 0 !     14I4A%1!  !    $1<  !)1
M!  !    $1<       "@A@$ C[$  /_; $, " 8&!P8%" <'!PD)" H,% T,
M"PL,&1(3#Q0=&A\>'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_; $,!"0D)# L,& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_  !$( #T Y@,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M@JH[@<_*:[\TQ>&J89PI23=UL5AZ<XR5T=G1117S)W!110: $Z]:Q=1\/Q7
M+VV(Y/[I^Z?\*VZ*N$Y0=XLF<(S5I'"?;-4T*<1DD+U\N3)4_3_ZU;EAXLLK
MDB.Y/V:7I\Y^4_0_XULW%M!=Q&*>-9$/9A7*:IX/?YI-.D+ _P#+*1N?P/\
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MP(_PUTP&***QG/FZ6125@HHHJ"@HHHH **** "BBB@!.]+110 4444 %%%%
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34444AA1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
